TrialAsian Pacific journal of cancer prevention : APJCP2025
A Phase 2 Prospective Trial of Capecitabine Plus Oxaliplatin as First-Line Therapy for Advanced Gall Bladder Cancers.
Vivek Goti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.